BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38642845)

  • 1. SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis.
    Liu H; Yue L; Hong W; Zhou J
    Life Sci; 2024 Jun; 347():122605. PubMed ID: 38642845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
    Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
    Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    Kaufmann B; Wang B; Zhong S; Laschinger M; Patil P; Lu M; Assfalg V; Cheng Z; Friess H; Hüser N; von Figura G; Hartmann D
    PLoS One; 2017; 12(7):e0180225. PubMed ID: 28700662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression.
    Chen Z; Lu X; Jia D; Jing Y; Chen D; Wang Q; Zhao F; Li J; Yao M; Cong W; He X
    Cell Death Dis; 2018 Jan; 9(2):59. PubMed ID: 29352111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis.
    Shi DM; Shi XL; Xing KL; Zhou HX; Lu LL; Wu WZ
    Cell Signal; 2020 Aug; 72():109650. PubMed ID: 32320856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.
    Choi HI; An GY; Baek M; Yoo E; Chai JC; Lee YS; Jung KH; Chai YG
    Sci Rep; 2021 Jun; 11(1):11799. PubMed ID: 34083693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
    Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
    Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
    Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
    Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma.
    Ma M; Zhou Y; Sun R; Shi J; Tan Y; Yang H; Zhang M; Shen R; Xu L; Wang Z; Fei J
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1063-1070. PubMed ID: 32556117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRG1 regulates endothelial-derived IL-33 to promote ischemia-reperfusion induced renal injury and fibrosis in mice.
    Liu L; Mao L; Wu X; Wu T; Liu W; Yang Y; Zhang T; Xu Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2551-2561. PubMed ID: 31228616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brg1 trans-activates endothelium-derived colony stimulating factor to promote calcium chloride induced abdominal aortic aneurysm in mice.
    Zhang X; Liu S; Weng X; Wu T; Yu L; Xu Y; Guo J
    J Mol Cell Cardiol; 2018 Dec; 125():6-17. PubMed ID: 30336142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
    Guerrero-Martínez JA; Reyes JC
    Sci Rep; 2018 Feb; 8(1):2043. PubMed ID: 29391527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.